PC

Pravin Pillai ( Cpa

Director Of Finance And Technical Accounting at Camber Pharmaceuticals Inc

Pravin Pillai is a CPA and CA with a Masters degree. Pravin has over 15 years of work experience, starting in 2001 as a Manager Accouts at Mysore Petrochemicals Limited. Taloja,Panvel. From 2005 to 2006, they worked as a Manager of Finance and Accounts at American Fuel Distributors, L.P. Pravin then became a Business and System Consultant at Fadel Partners from 2007 to 2010. During this time, they also worked as a Business and System Consultant at CDC Global Services from 2006 to 2010. In 2010, Pravin joined Camber Pharmaceuticals Inc as the Director of Finance and Technical Accounting.

Pravin Pillai has a strong education background in the field of finance and accounting. Pravin holds a CPA (Certified Public Accountant) degree from AICPA (American Institute of Certified Public Accountants). Pravin also holds a Chartered Accountants degree from The Institute of Chartered Accountants of India, where they specialized in audit, accounts, and taxation. Additionally, they have a degree in Management Accounting from the Institute of Cost Accountants of India and a Bachelor's Degree in Accounting, Finance, and Economics from the University of Mumbai. Pravin further enhanced their education by obtaining a Masters in Business Administration from Jamnalal Bajaj Institute of Management Studies (JBIMS) with a focus on Business Administration and Management General. Their extensive education in finance, accounting, and taxation has equipped Pravin with a strong foundation in these areas.

Location

Iselin, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Camber Pharmaceuticals Inc

Camber is made up of three groups with one common goal: to be the best generics company in the industry. Camber Pharmaceuticals is rapidly growing and had an industry-leading 28 product approvals in 2022. With the support of our parent company, Hetero, we are poised to have a record number of product approvals and launches in 2023. Hetero, a world leader in API production and vertical manufacturing, is the foundation upon which Camber has maintained a 99% service level for our customers for the past two years. Hetero is investing over $250 million in the next three years in Camber products. The research and development team consists of over 1,000 scientists working to expand the types of drugs Camber offers, including novel delivery systems and complex molecules.


Employees

51-200

Links